\nNovo Nordisk A\/S a devenit a doua companie european\u0103 care a dep\u0103\u015fit valoarea de pia\u0163\u0103 de 500 de miliarde de dolari, sus\u0163inut\u0103 de o perspectiv\u0103 optimist\u0103 pentru medicamentul s\u0103u de succes \u00eempotriva obezit\u0103\u0163ii, raporteaz\u0103 Bloomberg.<\/p>\n
\nNovo a dep\u0103\u015fit miercuri aceast\u0103 born\u0103, ajung\u00e2nd la un nivel atins doar de LVMH, proprietarul Dior, \u00een timp ce ac\u0163iunile sale \u015fi-au extins c\u00e2\u015ftigurile recente.<\/p>\n
\nCompania farmaceutic\u0103 danez\u0103 a dep\u0103\u015fit gigantul de lux, ajung\u00e2nd \u00een lumina reflectoarelor dup\u0103 ce Wegovy, medicamentul pentru obezitate, al\u0103turi de un alt medicament asociat pentru diabet, Ozempic, au demonstrat c\u0103 pot ajuta oamenii s\u0103 scape de greutatea nedorit\u0103 prin reducerea apetitului.<\/p>\n
\nRezultatele ob\u0163inute de Novo au st\u00e2rnit un nou optimism, deoarece compania a declarat c\u0103 veniturile ar putea cre\u015fte cu p\u00e2n\u0103 la 26% \u00een acest an, iar profitul opera\u0163ional cu p\u00e2n\u0103 la 29% la un curs de schimb constant. Orientarea pare conservatoare, potrivit analistului Michael Shah de la Bloomberg Intelligence.<\/p>\n
\nProduc\u0103torul de medicamente s-a luptat s\u0103 \u0163in\u0103 pasul cu cererea at\u00e2t pentru Wegovy, c\u00e2t \u015fi pentru Ozempic, care au \u00een comun acela\u015fi ingredient activ. Miercuri, firma a declarat c\u0103 a dublat num\u0103rul de doze ini\u0163iale de Wegovy pe care le expediaz\u0103 \u00een SUA, permi\u0163\u00e2nd unui num\u0103r mai mare de persoane s\u0103 \u00eenceap\u0103 tratamentul.<\/p>\n
\nCompania a anun\u0163at anul trecut investi\u0163ii de 8,7 miliarde de dolari pentru a-\u015fi spori capacitatea de produc\u0163ie.<\/p>\n","protected":false},"excerpt":{"rendered":"
Novo Nordisk A\/S a devenit a doua companie european\u0103 care a dep\u0103\u015fit valoarea de pia\u0163\u0103 de 500 de miliarde de dolari, sus\u0163inut\u0103 de o perspectiv\u0103 optimist\u0103 pentru medicamentul s\u0103u de succes \u00eempotriva obezit\u0103\u0163ii, raporteaz\u0103 Bloomberg. Novo a dep\u0103\u015fit miercuri aceast\u0103 born\u0103, ajung\u00e2nd la un nivel atins doar de LVMH, proprietarul Dior, \u00een timp ce ac\u0163iunile […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[272,246,9782,323,16559,32228,23948,519,10210],"class_list":["post-223719","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-companie","tag-crestere","tag-declaratii","tag-medicamente","tag-obezitate","tag-optimist","tag-perspectiva","tag-raportare","tag-succes"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/223719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=223719"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/223719\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=223719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=223719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=223719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}